$mnk а это часом не об ней речь

? А тоя не слежу за местными новостями: Mallinckrodt plc (OTC: MNKKQ) announced that the FDA issued a Complete Response Letter (CRL) for its New Drug Application (NDA) of terlipressin to treat adults with hepatorenal syndrome (HRS).